本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Eledon Pharmaceuticals, Inc.

3.36
-0.0200-0.59%
成交量:24.00万
成交额:82.38万
市值:2.01亿
市盈率:-4.51
高:3.56
开:3.44
低:3.34
收:3.38
数据加载中...
2022/03/24

重要事件披露

8-K - Current report
2022/03/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

重要事件披露

8-K - Current report
2022/01/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/09

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/07/02

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/05/18

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report
2021/04/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]